8-bromo-5-methoxy-1,2,3,4-tetrahydro-1,6-naphthyridine, 95.0%, 250mg

(1S,3S,4S)-ETHYL 4-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXYCYCLOHEXANECARBOXYLATE, 95.0%, 500mg

(R)-9-(2-Hydroxypropyl)adenine>98.0%(HPLC)(T)5g

Cilindri di miscelazione DURAN® Classe A, 250 ml, 2 Pezzo(i)

(4-(BIS(4-CHLOROPHENYL)METHYL)PIPERAZIN-1-YL)(5-METHYL-4-NITROISOXAZOL-3-YL)METHANONE, 95%, 10mg

3,5-Bis(trifluoromethyl)phenylacetic acid, 98.0%, 100g

3-Phenylsalicylic acid, 98.0%, 1g

7-Bromo-5-chloroindolin-2-one, 95.0%, 250mg

4-Nitrosodiphenylamine>97.0%(HPLC)25g

8-Bromo-1,8a-dihydro-imidazo[1,2-a]pyridine-2-carboxylic acid dimethylamide, 95.0%, 1g

7-Amino-5-bromoindole, 95.0%, 250mg

Methyl 2-(3-methylpyridin-2-yl)acetate, 95%, 1g

Pyrimidine-4-carboxamide, 95%, 250mg